First, there is a need for more comprehensive studies on the molecular and genetic drivers of metastasis, particularly in the context of ovarian cancer mutations, such as BRCA1/2 and homologous recombination deficiencies, which may predispose tumors to specific metastatic patterns. This evidence concerns the gene BRCA1 and ovarian carcinoma.